Cargando…
The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal malignancy with a dismal five-year survival rate. Despite remarkable improvements of cancer therapeutics in recent years, patients with PDAC barely benefit from them due to late diagnosis of the disease. Exosomes, sm...
Autores principales: | Hsu, Sheng-Kai, Jadhao, Mahendra, Liao, Wei-Ting, Chang, Wen-Tsan, Lin, I-Ling, Chiu, Chien-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046651/ https://www.ncbi.nlm.nih.gov/pubmed/36980662 http://dx.doi.org/10.3390/cancers15061776 |
Ejemplares similares
-
Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
por: Hsu, Sheng-Kai, et al.
Publicado: (2022) -
The Role of Nonapoptotic Programmed Cell Death — Ferroptosis, Necroptosis, and Pyroptosis — in Pancreatic Ductal Adenocarcinoma Treatment
por: Hsu, Sheng-Kai, et al.
Publicado: (2022) -
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
por: Makler, Amy, et al.
Publicado: (2022) -
Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma
por: Wang, Cheng, et al.
Publicado: (2021) -
Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges
por: Root, Alex, et al.
Publicado: (2018)